Skip to main content

Abcodia, OGT Partner on Cancer Biomarker Discovery

NEW YORK (GenomeWeb News) – Abcodia and Oxford Gene Technology announced today that they will collaborate on the discovery and validation of biomarkers for the early detection of pancreatic cancer.

Under the alliance, Abcodia will provide access to samples from its serum biobank taken from individuals up to seven years before the diagnosis of pancreatic cancer. OGT said that it will apply its functional protein array platform and its Genefficiency microRNA profiling array to identify pancreatic cancer-specific biomarkers that could potentially be used as indicators of developing pancreatic cancer.

Financial and other terms of the alliance were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.